Trial news: The AGITG currently has thirteen studies open to recruitment and five studies in follow up.
The table below details the trials that are currently accruing patients.
| Recruited | Target | Recruitment Period (months) | Date of First Site Open | |
| ACTICCA-1 | 6 | 50 | 36 | 25 July 2016 |
| ASCOLT | 344 | 400 | 48 | 18 June 2014 |
| DYNAMIC-III | 155 | 1000 | 54 | 09 October 2017 |
| DYNAMIC-Pancreas | 1 | 438 | 54 | 01 March 2019 |
| DYNAMIC-Rectal | 40 | 408 | 36 | 18 June 2018 |
| INTEGRATE II | 46 | 90 | 48 | 19 October 2016 |
| LIBERATE | 72 | 100 | 19 | 4 April 2018 |
| MODULATE | 53 | 90 | 24 | 13 September 2018 |
| MONARCC | 9 | 80 | 24 | 20 June 2018 |
| NABNEC | 28 | 70 | 36 | 15 September 2016 |
| RENO | 2 | 250 | 36 | 21 January 2019 |
| SPAR | 11 | 222 | 48 | 13 April 2018 |
| TOP GEAR | 208 | 280 | 112 | 29 September 2009 |
Recruitment figures are for Australian and New Zealand sites as at end March 2019.
Trial Results Lay Summaries (click on the links below):
ALaCaRT
ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST